Plexus Corp. (NASDAQ:PLXS) Receives $189.20 Average Target Price from Analysts

Shares of Plexus Corp. (NASDAQ:PLXSGet Free Report) have been given an average rating of “Moderate Buy” by the six analysts that are currently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $189.20.

Several research analysts recently weighed in on the stock. Needham & Company LLC lifted their price objective on shares of Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Sidoti lowered shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a report on Friday, October 24th. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. Williams Trading set a $195.00 price target on shares of Plexus in a report on Wednesday, January 28th. Finally, Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, February 5th.

Get Our Latest Research Report on Plexus

Insider Buying and Selling

In other news, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the firm’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $203.06, for a total transaction of $873,767.18. Following the sale, the chief accounting officer owned 20,099 shares of the company’s stock, valued at $4,081,302.94. This trade represents a 17.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Todd P. Kelsey sold 8,120 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $205.65, for a total value of $1,669,878.00. Following the completion of the transaction, the chief executive officer owned 78,598 shares of the company’s stock, valued at $16,163,678.70. This represents a 9.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 30,951 shares of company stock valued at $6,077,670. 1.78% of the stock is owned by company insiders.

Institutional Investors Weigh In On Plexus

Several large investors have recently made changes to their positions in PLXS. Allworth Financial LP lifted its position in Plexus by 20.8% in the 4th quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock valued at $44,000 after acquiring an additional 52 shares in the last quarter. Oregon Public Employees Retirement Fund raised its stake in shares of Plexus by 1.2% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,175 shares of the technology company’s stock valued at $908,000 after purchasing an additional 71 shares during the period. Uncommon Cents Investing LLC raised its stake in shares of Plexus by 0.8% in the 4th quarter. Uncommon Cents Investing LLC now owns 9,925 shares of the technology company’s stock valued at $1,459,000 after purchasing an additional 75 shares during the period. Congress Asset Management Co. lifted its holdings in shares of Plexus by 0.5% in the third quarter. Congress Asset Management Co. now owns 16,245 shares of the technology company’s stock valued at $2,350,000 after purchasing an additional 88 shares in the last quarter. Finally, Choreo LLC lifted its holdings in shares of Plexus by 1.9% in the fourth quarter. Choreo LLC now owns 5,131 shares of the technology company’s stock valued at $767,000 after purchasing an additional 94 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.

Plexus Trading Down 2.7%

PLXS opened at $199.08 on Tuesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.75. The company has a market cap of $5.33 billion, a price-to-earnings ratio of 30.96 and a beta of 0.81. The firm has a 50 day simple moving average of $170.64 and a 200 day simple moving average of $150.31. Plexus has a fifty-two week low of $103.43 and a fifty-two week high of $211.84.

Plexus (NASDAQ:PLXSGet Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. The firm had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period last year, the firm earned $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, sell-side analysts anticipate that Plexus will post 5.9 earnings per share for the current year.

About Plexus

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Articles

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.